Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Quantensicherheit! Ist diese Aktie noch völlig unterschätzt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QQGU | ISIN: CA4236943060 | Ticker: 2VF0
Frankfurt
17.11.26 | 15:25
0,015 Euro
-29,27 % -0,006
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HEMOSTEMIX INC Chart 1 Jahr
5-Tage-Chart
HEMOSTEMIX INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0210,02823:00
0,0220,02622:00

Aktuelle News zur HEMOSTEMIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.10.Hemostemix Inc (2): Hemostemix receives Bahamian OK for VesCell study3
08.10.Hemostemix Inc (2): Hemostemix 13,645,000-share private placement1
07.10.Hemostemix Inc.: Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update638Calgary, Alberta--(Newsfile Corp. - October 7, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces that it has received full approval from the National...
► Artikel lesen
28.09.Centurion One Capital Corp.: Hemostemix to Attend Centurion One Capital's 4th Annual Bahamas Summit425Calgary, Alberta--(Newsfile Corp. - September 28, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that it is presenting at the Centurion...
► Artikel lesen
24.09.Hemostemix Inc (2): Hemostemix closes third tranche of private placement1
23.09.Hemostemix Inc.: Hemostemix Non Brokered Private Placement519Calgary, Alberta--(Newsfile Corp. - September 23, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it is filing a Form 4B to obtain...
► Artikel lesen
HEMOSTEMIX Aktie jetzt für 0€ handeln
21.08.Hemostemix Inc (2): Hemostemix talks up enrolment to hear Shankle3
20.08.Hemostemix Inc.: Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell Under LARTA674Leading cognitive-disorders specialist, Dr. William Shankle, will discuss vascular cognitive impairment, vascular dementia and the proposed clinical trial of VesCell (ACP-01) today at 12:00 EST...
► Artikel lesen
12.08.Hemostemix Inc (2): Hemostemix names longevity trial principal investigator2
12.08.Hemostemix Inc.: Dr. Ernst von Schwarz, Principal Investigator of Hemostemix VesCell Longevity Clinical Trial1.058Calgary, Alberta--(Newsfile Corp. - August 12, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the appointment of Prof. Dr....
► Artikel lesen
31.07.Hemostemix Inc (2): Hemostemix closes $322,250 second tranche of placement1
31.07.Hemostemix Inc.: Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026732Calgary, Alberta--(Newsfile Corp. - July 30, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed the second tranche...
► Artikel lesen
29.07.Hemostemix Inc (2): Hemostemix drafts VesCell phase 1 trial protocol3
28.07.Hemostemix Inc.: Hemostemix' Longevity Phase I Clinical Trial Leveraging VesCell's Excellent Results726Calgary, Alberta--(Newsfile Corp. - July 28, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), an autologous (patient's own stem cells) regenerative...
► Artikel lesen
23.07.Hemostemix Inc (2): Hemostemix grants options to buy 6.28 million shares6
22.07.Hemostemix Inc.: Hemostemix Grants Stock Options498Calgary, Alberta--(Newsfile Corp. - July 22, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that in accordance with its stock...
► Artikel lesen
09.07.Hemostemix Inc (2): Hemostemix files commercialization application3
08.07.Hemostemix Inc.: Commercialization Application Filed by Hemostemix for the Treatment of Vascular Dementia, Angina and Pain648Calgary, Alberta--(Newsfile Corp. - July 8, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company"), the leading autologous (patient's own stem cells) regenerative medicine...
► Artikel lesen
26.06.Hemostemix Inc (2): Hemostemix closes $360,000 first tranche of placement2
26.06.Hemostemix Inc.: Hemostemix Closes $360,000 First Tranche of Private Placement475Calgary, Alberta--(Newsfile Corp. - June 26, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed the first tranche...
► Artikel lesen
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1